HMGB1 and female reproductive system disorder: Future studies should validate the values of HMGB1 and histone H3 in the large number of patients with established DIC scoring systems, various underlying disease types including obstetric and gynecological diseases, DIC types with enhanced-fibrinolysis and suppressed-fibrinolysis, other DAMPs, and coagulation biomarkers.